Beacon Pointe Advisors LLC purchased a new stake in Cigna Group (NYSE:CI - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 39,957 shares of the health services provider's stock, valued at approximately $11,015,000.
Several other institutional investors have also recently modified their holdings of the stock. Wilkerson Advisory Group LLC acquired a new position in Cigna Group in the 4th quarter valued at about $25,000. Osbon Capital Management LLC acquired a new stake in shares of Cigna Group during the 2nd quarter worth about $26,000. Kemnay Advisory Services Inc. purchased a new stake in shares of Cigna Group during the fourth quarter worth about $29,000. Prosperity Bancshares Inc purchased a new stake in shares of Cigna Group during the fourth quarter worth about $29,000. Finally, Cedar Mountain Advisors LLC raised its position in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock valued at $29,000 after buying an additional 68 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
CI has been the subject of several research analyst reports. Mizuho upped their price target on shares of Cigna Group from $330.00 to $340.00 and gave the stock an "outperform" rating in a research report on Monday, June 8th. Wells Fargo & Company lifted their price target on shares of Cigna Group from $305.00 to $307.00 and gave the company an "equal weight" rating in a report on Friday, July 31st. Piper Sandler lowered their price objective on shares of Cigna Group from $370.00 to $346.00 and set an "overweight" rating for the company in a research note on Wednesday, June 3rd. Raymond James Financial downgraded Cigna Group from a "strong-buy" rating to an "outperform" rating and dropped their price objective for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Finally, Morgan Stanley increased their target price on Cigna Group from $355.00 to $361.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 20th. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $339.45.
Read Our Latest Stock Analysis on Cigna Group
Cigna Group Stock Up 0.4%
Shares of Cigna Group stock opened at $278.89 on Friday. The company has a market capitalization of $73.69 billion, a P/E ratio of 11.54, a PEG ratio of 0.96 and a beta of 0.29. The business's fifty day moving average price is $283.52 and its two-hundred day moving average price is $281.39. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76.
Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group's revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts forecast that Cigna Group will post 30.51 EPS for the current year.
Cigna Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group's dividend payout ratio (DPR) is 25.82%.
Insider Transactions at Cigna Group
In other news, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares of the company's stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company's stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company's stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 23,012 shares of company stock worth $6,386,550 in the last three months. 0.60% of the stock is currently owned by company insiders.
About Cigna Group
(
Free Report)
Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.